BETA DRUGS LIMITED

Highlights Beta Drugs Limited

Equities

BETA

INE351Y01019

Delayed NSE India S.E. Other stock markets 06:02:46 2024-05-16 EDT			5-day change	1st Jan Change
1,180 ^INR	-2.46%		-8.01%	-19.73%

2023	Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
2023	Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2023	11-07	CI
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-08	CI
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2022	22-10-27	CI
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	22-04-26	CI
Beta Drugs Limited Gets DCGI Approval for Its New Drug KABONIB	22-04-11	CI
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2021	21-11-10	CI
Beta Drugs Ltd Receives WHO- GMP Approval for Its API Plant	21-07-19	CI
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2020	20-11-12	CI
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2020	20-05-29	CI
Beta Drugs Ltd. Receives Registration Certificates for 20 Injectables from Ministry of Health Uzbekistan	20-04-27	CI
Beta Drugs Limited acquired Adley Lab Ltd from group of shareholders for INR 45 million.	19-10-24	CI
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2019	19-10-22	CI
Beta Drugs Limited agreed to acquire Adley Lab Ltd from a group of shareholders for INR 45.04 million	19-05-29	CI
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2019	19-05-12	CI
Beta Drugs Limited has completed an IPO in the amount of INR 195.16 million.	17-10-11	CI
Beta Drugs Limited has filed an IPO.	17-08-28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW